Alzheimer Disease Detection Techniques and Methods: A Review

Brain pathological changes linked with Alzheimer's disease (AD) can be measured with Neuroimaging. In the past few years, these measures are rapidly integrated into the signatures of Alzheimer disease (AD) with the help of classification frameworks which are offering tools for diagnosis and prognosis. Here is the review study of Alzheimer's disease based on Neuroimaging and cognitive impairment classification. This work is a systematic review for the published work in the field of AD especially the computer-aided diagnosis. The imaging modalities include 1) Magnetic resonance imaging (MRI) 2) Functional MRI (fMRI) 3) Diffusion tensor imaging 4) Positron emission tomography (PET) and 5) amyloid-PET. The study revealed that the classification criterion based on the features shows promising results to diagnose the disease and helps in clinical progression. The most widely used machine learning classifiers for AD diagnosis include Support Vector Machine, Bayesian Classifiers, Linear Discriminant Analysis, and K-Nearest Neighbor along with Deep learning. The study revealed that the deep learning techniques and support vector machine give higher accuracies in the identification of Alzheimer’s disease. The possible challenges along with future directions are also discussed in the paper

Efficient Algorithm for Distinction Mild Cognitive Impairment from Alzheimer’s Disease Based on Specific View FCM White Matter Segmentation and Ensemble Learning

Purpose: Alzheimer's Disease (AD) is in the dementia group and is one of the most prevalent neurodegenerative disorders. Between existing characteristics, White Matter (WM) is a known marker for AD tracking, and WM segmentation in MRI based on clustering can be used to decrease the volume of data. Many algorithms have been developed to predict AD, but most concentrate on the distinction of AD from Cognitive Normal (CN). In this study, we provided a new, simple, and efficient methodology for classifying patients into AD and MCI patients and evaluated the effect of the view dimension of Fuzzy C Means (FCM) in prediction with ensemble classifiers. Materials and Methods: We proposed our methodology in three steps; first, segmentation of WM from T1 MRI with FCM according to two specific viewpoints (3D and 2D). In the second, two groups of features are extracted: approximate coefficients of Discrete Wavelet Transform (DWT) and statistical (mean, variance, skewness) features. In the final step, an ensemble classifier that is constructed with three classifiers, K-Nearest Neighbor (KNN), Decision Tree (DT), and Linear Discriminant Analysis (LDA), was used. Results: The proposed method has been evaluated by using 1280 slices (samples) from 64 patients with MCI (32) and AD (32) of the ADNI dataset. The best performance is for the 3D viewpoint, and the accuracy, precision, and f1-score achieved from the methodology are 94.22%, 94.45%, and 94.21%, respectively, by using a ten-fold Cross-Validation (CV) strategy. Conclusion: The experimental evaluation shows that WM segmentation increases the performance of the ensemble classifier, and moreover the 3D view FCM is better than the 2D view. According to the results, the proposed methodology has comparable performance for the detection of MCI from AD. The low computational cost algorithm and the three classifiers for generalization can be used in practical application by physicians in pre-clinical

A Review on Explainable Artificial Intelligence for Healthcare: Why, How, and When?

Artificial intelligence (AI) models are increasingly finding applications in the field of medicine. Concerns have been raised about the explainability of the decisions that are made by these AI models. In this article, we give a systematic analysis of explainable artificial intelligence (XAI), with a primary focus on models that are currently being used in the field of healthcare. The literature search is conducted following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) standards for relevant work published from 1 January 2012 to 02 February 2022. The review analyzes the prevailing trends in XAI and lays out the major directions in which research is headed. We investigate the why, how, and when of the uses of these XAI models and their implications. We present a comprehensive examination of XAI methodologies as well as an explanation of how a trustworthy AI can be derived from describing AI models for healthcare fields. The discussion of this work will contribute to the formalization of the XAI field.Comment: 15 pages, 3 figures, accepted for publication in the IEEE Transactions on Artificial Intelligenc

A Review on the use of Artificial Intelligence Techniques in Brain MRI Analysis

Over the past 20 years, the global research going on in Artificial Intelligence in applica-tions in medication is a venue internationally, for medical trade and creating an ener-getic research community. The Artificial Intelligence in Medicine magazine has posted a massive amount. This paper gives an overview of the history of AI applications in brain MRI analysis to research its effect at the wider studies discipline and perceive de-manding situations for its destiny. Analysis of numerous articles to create a taxono-my of research subject matters and results was done. The article is classed which might be posted between 2000 and 2018 with this taxonomy. Analyzed articles have excessive citations. Efforts are useful in figuring out popular studies works in AI primarily based on mind MRI analysis throughout specific issues. The biomedical prognosis was ruled by way of knowledge engineering research in its first decade, whilst gadget mastering, and records mining prevailed thereafter. Together these two topics have contributed a lot to the latest medical domain

Editor's Note

In today’s world, we have witnessed an onset of multimedia content being uploaded/downloaded and shared through a multitude of platforms both online and offline. In support of this trend, multimedia processing and analyzing has become very popular in all kinds of information extraction and attracts research interest from both academia and industry. This is to be expected as the multimedia digital world is worth trillions of dollars worldwide. However, multimedia information is hard to encode, interpret and recognize because it is combined with many complex components. Recently, there are many research areas related to the overall notion of intelligent multimedia processing. Therefore, the collected papers in this special issue provide a systematic overview and state-of-the-art research in the field of intelligent multimedia processing and analyzing system and outline new developments in fundamental, theorems, approaches, methodologies, software systems, recommendations, and real-world applications in this area

Differentiation of Alzheimer's disease dementia, mild cognitive impairment and normal condition using PET-FDG and AV-45 imaging : a machine-learning approach

Nous avons utilisé l'imagerie TEP avec les traceurs F18-FDG et AV45 en conjonction avec les méthodes de classification du domaine du "Machine Learning". Les images ont été acquises en mode dynamique, une image toutes les 5 minutes. Les données ont été transformées par Analyse en Composantes Principales et Analyse en Composantes Indépendantes. Les images proviennent de trois sources différentes: la base de données ADNI (Alzheimer's Disease Neuroimaging Initiative) et deux protocoles réalisés au sein du centre TEP de l'hôpital Purpan. Pour évaluer la performance de la classification nous avons eu recours à la méthode de validation croisée LOOCV (Leave One Out Cross Validation). Nous donnons une comparaison entre les deux méthodes de classification les plus utilisées, SVM (Support Vector Machine) et les réseaux de neurones artificiels (ANN). La combinaison donnant le meilleur taux de classification semble être SVM et le traceur AV45. Cependant les confusions les plus importantes sont entre les patients MCI et les sujets normaux. Les patients Alzheimer se distinguent relativement mieux puisqu'ils sont retrouvés souvent à plus de 90%. Nous avons évalué la généralisation de telles méthodes de classification en réalisant l'apprentissage sur un ensemble de données et la classification sur un autre ensemble. Nous avons pu atteindre une spécificité de 100% et une sensibilité supérieure à 81%. La méthode SVM semble avoir une meilleure sensibilité que les réseaux de neurones. L'intérêt d'un tel travail est de pouvoir aider à terme au diagnostic de la maladie d'Alzheimer.We used PET imaging with tracers F18-FDG and AV45 in conjunction with the classification methods in the field of "Machine Learning". PET images were acquired in dynamic mode, an image every 5 minutes.The images used come from three different sources: the database ADNI (Alzheimer's Disease Neuro-Imaging Initiative, University of California Los Angeles) and two protocols performed in the PET center of the Purpan Hospital. The classification was applied after processing dynamic images by Principal Component Analysis and Independent Component Analysis. The data were separated into training set and test set. To evaluate the performance of the classification we used the method of cross-validation LOOCV (Leave One Out Cross Validation). We give a comparison between the two most widely used classification methods, SVM (Support Vector Machine) and artificial neural networks (ANN) for both tracers. The combination giving the best classification rate seems to be SVM and AV45 tracer. However the most important confusion is found between MCI patients and normal subjects. Alzheimer's patients differ somewhat better since they are often found in more than 90%. We evaluated the generalization of our methods by making learning from set of data and classification on another set . We reached the specifity score of 100% and sensitivity score of more than 81%. SVM method showed a bettrer sensitivity than Artificial Neural Network method. The value of such work is to help the clinicians in diagnosing Alzheimer's disease

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer’s disease. In the work, the term “pattern” stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called “region of interest (ROI)”. In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the characteristics of the given data, given some prior anatomical knowledge. A Gaussian Mixture Model (GMM) and model selection are combined to return a clustering of voxels that may serve for the definition of ROIs. Experiments on both an in-house dataset and data of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) suggest that the proposed approach arrives at a better diagnosis than a merely anatomical approach or conventional statistical hypothesis testing

Early Detection of Neurodegenerative Diseases from Bio-Signals: A Machine Learning Approach

Given the fact that people, especially in advanced countries, are living longer due to the advancements in medical sciences which resulted in the prevalence of age-related diseases like Alzheimer’s and dementia. The occurrence of such diseases continues to increase and ultimately the cost of caring for these groups will become unsustainable. Addressing this issue has reached a critical point and failing to provide a strategic way forward will negatively affect patients, national health services and society as a whole.Three distinctive development stages of neurodegenerative diseases (Retrogenesis, Cognitive Impairment and Gait Impairment) motivated me to divide this research work into two main parts. To fully achieve the purpose of early detection/diagnosis, I aimed at analysing the gait signals as well as EEG signals, separately, as both of these signals severely get affected by any neurological disease.The first part of this research work focuses on the discrimination analysis of gait signals of different neurodegenerative diseases (Parkinson’s, Huntington, and Amyotrophic Lateral Sclerosis) and also of control subjects. This involves relevant feature extraction, solving the issues of imbalanced datasets and missing entries and lastly classification of multiclass datasets. For the classification and discrimination of gait signals, eleven (11) classifiers are selected representing linear, non-linear and Bayes normal classification techniques. Results revealed that three classifiers have provided us with higher accuracy rate which are UDC, LDC and PARZEN with 65%, 62.5% and 60% accuracy, respectively. Further, I proposed and developed a new classifier fusion strategy that combined classification algorithms with combining rules (voting, product, mean, median, maximum and minimum). It generates better results and classifies subjects more accurately than base-level classifiers.The last part of this research work is based on the rectification and computation of EEG signals of mild Alzheimer’s disease patients and control subjects. To detect the perturbation in EEG signals of Alzheimer’s patients, three neural synchrony measurement techniques; phase synchrony, magnitude squared coherence and cross correlation are applied on three different databases of mild Alzheimer’s disease (MiAD) patients and healthy subjects. I have compared right and left temporal parts of brain with rest of the brain area (frontal, central and occipital), as temporal regions are relatively the first ones to be affected by Alzheimer’s. Two novel methods are proposed to compute the neural synchronization of the brain; Average synchrony measure and PCA based synchrony measure. These techniques are evaluated for three different datasets of MiAD patients and control subjects using the Wilcoxon ranksum test (Mann-Whitney U test). Results demonstrated that PCA based method helped us to find more significant features that can be used as biomarkers for the early diagnosis of Alzheimer’s